In Response: We welcome the critiques of Nasci et al. (1) , who may have misinterpreted the point of our Dispatch. Regarding identification of Heartland virus (HLV) in farm animals, in our article (2), we stated that "the viruses detected in this region are most likely HLV or close relatives of HLV," which indicates that the exact identification of the viruses in the animals in Minnesota will not be confirmed until the viruses are isolated and/or the genomic sequence data are available.
The underlying data were obtained with an ELISA specific to severe fever with thrombocytopenia syndrome virus (SFTSV). The conclusion was based on our knowledge, at the time our manuscript was submitted, that in North America no other known phleboviruses of this expanded Uukuniemi group that contains SFTSV and HLV were reported to be cross-reactive with SFTSV. When tested by using our reagent, SFTSV was not crossreactive with Rift Valley fever virus. Related phleboviruses of this group (e.g., Bhanja, Palma, Forecariah, and Kismayo viruses) have not been reported in North America (3) . Phleboviruses of this group, such as Murre virus and RML-105355 virus, and Sunday Canyon virus, were isolated in Alaska and Texas, respectively, but are not crossreactive with SFTSV (4).
Other bunyaviruses in North America (e.g., Cache Valley virus and California serogroup viruses) are distantly related and have ≈11% amino acid sequence homology to SFTSV. The recently characterized Lone Star virus appears to be the closest relative to SFTSV and HLV and may cross-react with SFTSV and HLV, as also suggested by Nasci et al., but this virus is apparently known only from 1 isolate obtained in 1967 (5) . These data suggest that SFTSV is not serologically cross-reactive with the known Unkuniemi group viruses that are currently being transmitted in North America. Our report shows that tickborne LETTERS phleboviruses, which are closely related to SFTSV and HLV, may be more generally distributed in the midwestern United States and emphasizes the need to substantiate our serologic evidence with virus isolation and genomic characterization, which are underway.
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Infectious Schmallenberg Virus from Bovine Semen, Germany
To the Editor: The teratogenic Schmallenberg virus (SBV) (genus Orthobunyavirus) was detected in bovine semen in a recent German field study (1) . Vector-borne transmission by Culicoides spp. biting midges is most common (2), but venereal transmission of SBV might contribute to the spread of this virus to previously unaffected regions. We investigated the infectivity of SBV RNA-positive semen by experimental subcutaneous injection of cattle and interferon α/β receptor-deficient (IFNAR -/-) mice (3). Commercially produced semen straws with egg yolk-based diluent were used for the injection of 6-to 9-month-old heifers. The straws originated from 6 semen batches (quantification cycle [C q ] values 26.4-36.4) collected from 6 bulls (designated A-C and E-G) during August and September 2012 (1). To increase the probability of SBV infection of injected cattle, 5 straws of semen (≈220 µL each) from 1 batch from an individual bull were pooled and diluted in minimal essential medium with antibiotics to 4 mL. Six cattle (C1-6) were subcutaneously inoculated, each with a pool from 1 of the 6 bulls. To investigate the infectivity of a single insemination dose (1 straw), 5 cattle (C7-C11) were subcutaneously injected with single straws from bull F that had been confirmed to contain infectious SBV. Serum samples were obtained on several days (Figure) , and clinical signs and rectal body temperatures for the injected cattle were monitored daily.
In addition, 20 SBV RNA-positive semen batches (C q 25.9 to 36.5) collected from 11 bulls (A-K) during August-November 2012 (1) were subcutaneously injected into 40 IFNAR -/-mice (4-6 weeks old). For each batch, 2 mice were each injected with half of a semen straw (80-120 µL). All mice were monitored clinically and weighed daily. Samples of serum, liver, and spleen were harvested immediately after euthanasia at 22 days postinjection (dpi).
All serum samples and organ homogenates were tested for SBV RNA by using small segment-specific quantitative reverse transcription PCR (4). Serum samples were tested for SBV-specific antibodies by using the ID Screen Schmallenberg Virus Competition ELISA (IDvet, Montpellier, France), according to the manufacturer's instructions; selected serum samples were also tested by neutralization test against an original SBV isolate from Germany, as described (5).
SBV infection was confirmed in 5 of 11 injected cattle: C3, C5, and C9-C11. SBV RNA (C q 25.0-29.3) was first detected in serum at 3 to 6 dpi and persisted for 2-4 days. Seroconversion occurred at 8-12 dpi (Figure) . None of the SBV-infected animals showed obvious clinical signs or fever; this finding is in accordance with reports of subclinical SBV infection in adult cattle (5-7). Samples from the other 6 cattle and all IFNAR -/-mice had negative results (data not shown).
The 2 infectious semen batches contained moderate (C q 26.4) or low (C q 34.2) viral loads of SBV RNA, indicating that a high sensitivity is required for reliable SBV RNA detection in semen samples (1) . The onset of SBV infection in the 3 animals injected with single semen straws ranged from 3 to 5 dpi, and not every straw was infectious, although biologic and technical replicates of straws from 1 semen batch showed similar PCR results (data not shown) (1). Possible explanations for differences in the infectivity of individual straws are that the viral RNA load of an SBV-containing straw does not necessarily correlate with infectivity or that the infectivity of 1 straw is lower than the minimal cattle
